Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Afya Limited
  6. News
  7. Summary
    AFYA   KYG011251066

AFYA LIMITED

(AFYA)
  Report
Delayed Quote. Delayed Nasdaq - 10/22 04:00:00 pm
17.4 USD   -4.24%
10/22AFYA : Sell Side Day
PU
10/01AFYA : Acquires Pharmaceutical Solutions Provider RX PRO
MT
10/01AFYA : RX PRO Acquisition
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Afya : Sustainalytics ESG Risk Rating is Publicly Available

09/28/2021 | 05:52pm EDT

AFYA'S SUSTAINALYTICS ESG RISK RATING IS PUBLICLY AVAILABLE

September xx, 2021 - Afya Limited or Afya (Nasdaq: AFYA) announces that Sustainalytics, a leading ESG and corporate governance research firm, has rated Afya as a "low risk" ESG Risk Rating company and in the 10th percentile in the Sustainalytics database of over 13,500 organizations as of September, 2021. Afya is at low risk of experiencing material financial impacts from ESG factors, due to its low exposure and good policies and applied practices. For further information, please access: https://www.sustainalytics.com/.

About Afya:

Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-endphysician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering digital products to help doctors enhance their healthcare services through their whole career.

Contact: Investor Relations: ir@afya.com.br

Disclaimer

Afya Ltd. published this content on 28 September 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 28 September 2021 21:51:04 UTC.


ę Publicnow 2021
All news about AFYA LIMITED
10/22AFYA : Sell Side Day
PU
10/01AFYA : Acquires Pharmaceutical Solutions Provider RX PRO
MT
10/01AFYA : RX PRO Acquisition
PU
10/01AFYA : Limited Announces the Acquisition of RX PRO
BU
10/01AFYA : Announces the Acquisition of RX PRO (Form 6-K)
PU
10/01AFYA : Institutional Presentation
PU
10/01Afya Limited acquired RX PRO Services for BRL 56.4 million.
CI
09/28AFYA : Sustainalytics ESG Risk Rating Is Publicly Available
BU
09/28AFYA : Sustainalytics ESG Risk Rating is Publicly Available
PU
08/27AFYA : Announces Second-Quarter and First Half 2021 Financial Results Strong Operational P..
PU
More news
Analyst Recommendations on AFYA LIMITED
More recommendations
Financials
Sales 2021 1 676 M 297 M 297 M
Net income 2021 390 M 69,1 M 69,1 M
Net Debt 2021 819 M 145 M 145 M
P/E ratio 2021 23,9x
Yield 2021 0,31%
Capitalization 9 154 M 1 621 M 1 621 M
EV / Sales 2021 5,95x
EV / Sales 2022 4,58x
Nbr of Employees 5 260
Free-Float 39,5%
Chart AFYA LIMITED
Duration : Period :
Afya Limited Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends AFYA LIMITED
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Last Close Price 98,28 BRL
Average target price 158,83 BRL
Spread / Average Target 61,6%
EPS Revisions
Managers and Directors
VirgÝlio Deloy Capobianco Gibbon Chief Executive Officer
Luis AndrÚ Carpintero Blanco Chief Financial Officer
Nicolau Carvalho Esteves Chairman
Vanessa Claro Lopes Independent Director
Miguel Filisbino de Paula Independent Director
Sector and Competitors